PBGENE-HbE

N/A

Report date: 2023/08/04 18:05:24

Base Information

Drug NamePBGENE-HbE
Drug Alias NamePBGENE-HbE
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceHemoglobin beta chain stimulants
TargetsHemoglobin beta chain
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Biosciences Inc
Inactive CompaniesN/A
Active Indicationsbeta-ThalassemiaAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A